Close Menu

DTC genetic testing

MPR News reports on efforts to tighten protections for genetic testing customers.

During a conference call to discuss the firm's second-quarter results, CEO and President Francis deSouza also highlighted potential growth from clinical sequencing.

23andMe and GlaxoSmithKline's partnership has uncovered half a dozen drug targets but also raised ethical questions, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Upgrade Time?

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

Give All the Data

CNBC reports that 23andMe is piloting a new program to incorporate customers' medical histories and lab tests with their genetic data.

The San Diego-based firm said it expects second quarter revenues of $835 million, short of the average analyst estimate of $888 million.

Bloomberg reports that some of genetic testing firm Vitagene's records were exposed online, including ones containing genetic information.

Just for Fun?

Slate's Jane Hu compares some at-home genetic tests to astrology.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.